For Q1 FY2026, GoodRx reported revenue of $194.0 million, a decrease of 4.4% year-over-year. Net income was $1.2 million, down 89.4% from the prior year. Operating income fell 40.1% to $14.0 million, and diluted EPS was $0.00, a 100% decline. The company held $235.7 million in cash, with total equity of $622.0 million and long-term debt of $482.4 million.
•Revenue declined 4.4% YoY to $194.0 million.
•Net income dropped 89.4% to $1.2 million.
•Operating income fell 40.1% to $14.0 million.
•Diluted EPS was $0.00, down 100% YoY.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.
GoodRx offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform.
Additionally, it provides healthcare products and solutions for dogs, cats, and pets. The company serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. Founded in 2011, the company is headquartered in Santa Monica, California.
GoodRx Holdings, Inc. operates a price comparison platform that enables consumers to compare prices and save on prescription drug purchases in the United States. The company provides curated, geographically relevant prescription pricing and access to negotiated prices. It also offers other healthcare products and services, including subscription programs, pharma manufacturer solutions, and telehealth services through the GoodRx Care platform. Additionally, GoodRx provides healthcare products and solutions for pets such as dogs and cats. Founded in 2011, the company is headquartered in Santa Monica, California.
On which stock exchange is GoodRx (GDRX) listed and in what currency?
GoodRx Holdings, Inc. is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol GDRX. The company's stock trades in United States Dollars (USD), which is the official currency of the United States where the company is headquartered and operates.
What sector and industry does GoodRx (GDRX) belong to?
GoodRx Holdings, Inc. operates in the Healthcare sector, specifically within the Health Information Services industry. This means the company focuses on providing health-related information and digital tools to consumers, rather than directly manufacturing or distributing pharmaceuticals. Its platform helps users navigate prescription drug pricing and access healthcare services, aligning with the broader health information technology space.
Where is GoodRx (GDRX) headquartered and what markets does it serve?
GoodRx Holdings, Inc. is headquartered in Santa Monica, California, United States. The company primarily serves the United States market, offering its price comparison platform and related healthcare services to consumers across the country. Its services include access to negotiated prescription prices, telehealth via GoodRx Care, and pet healthcare solutions. The company also serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies.
How does GoodRx (GDRX) make money?
GoodRx generates revenue through its price comparison platform, which provides consumers with access to negotiated prescription drug prices. The company earns fees from pharmacies and pharmacy benefit managers when consumers use GoodRx discounts to fill prescriptions. Additionally, GoodRx offers subscription programs and pharma manufacturer solutions, which likely involve marketing or data services to pharmaceutical companies. The telehealth services through GoodRx Care also contribute to revenue, as do healthcare products and solutions for pets. The company's business model revolves around connecting consumers with affordable prescription options and monetizing those transactions.